Isabelle Kenyon, Calibrate founder and CEO
Type 2 diabetes drugs and weight loss: Calibrate's model starts with pharma and builds out
Calibrate is looking to upend the weight loss industry. And thanks to the drug industry, it’s got a secret weapon – GLP-1 meds.
Over the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
